Component

MAO-B activity in the 2016 RA assay, enzyme species unresolved

MAO-B activity in the 2016 RA assay, enzyme species unresolved

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. RA inhibited MAO-B in vitro, IC50 184.6 micromolar.

    Experimental context and source evidence
    evidence_access
    Indexed primary abstract/metadata only; unextracted doses, figures and methods remain unknown.
    experimental_contrast
    {"intervention": "RA concentration series", "comparator": "No RA", "endpoint": "RA inhibited MAO-B in vitro, IC50 184.6 micromolar.", "effect_direction": "decrease", "combination": "single", "conditions": []} Explicit extracted experimental comparison; recorded from source.
    experimental_model
    2016 cell-free enzyme assay; species unresolved in accessible abstract.
    interpretation_status
    Recorded from source with stated access limits; ungraded, not independent replication.
    limitations
    Limited to the recorded preparation, model, exposure and endpoint. Does not establish a human dietary deficiency, clinical benefit or unique molecular mediation.
    nutrient_topic
    Rosmarinic acid collection; exact intervention and molecular form govern interpretation. · Rosmarinic acid
    plain_language
    RA inhibited MAO-B in vitro, IC50 184.6 micromolar.
    primary_references
    Combining in vitro and in silico approaches to evaluate the multifunctional profile of rosmarinic acid from Blechnum brasiliense on targets related to neurodegeneration. | https://pubmed.ncbi.nlm.nih.gov/27270453/ | https://doi.org/10.1016/j.cbi.2016.06.005
    source_locator
    Reviewed reference ra-maob-inhibition; MAO-A inhibition was not time-dependent, consistent with reversibility. No human neuronal target engagement was measured.

    Rosmarinic acid: detailed mechanisms of action (reviewed 10 October 2026) · lines 129–135

    AI-assisted original curation of primary studies; claim-local access and experimental limitations stated. Includes original-draft correction history. No independent replication claimed. · supports · 2016 cell-free enzyme assay; species unresolved in accessible abstract. · Recorded from source · Recorded from source

    ### ra-maob-inhibition RA inhibited MAO-B in vitro, IC50 184.6 micromolar. MAO-A inhibition was not time-dependent, consistent with reversibility. No human neuronal target engagement was measured. Model and exposure: 2016 cell-free enzyme assay; species unresolved in accessible abstract. Limitations: Limited to the recorded preparation, model, exposure and endpoint. Does not establish a human dietary deficiency, clinical benefit or unique molecular mediation. Reference: Combining in vitro and in silico approaches to evaluate the multifunctional profile of rosmarinic acid from Blechnum brasiliense on targets related to neurodegeneration. | 2016 | https://pubmed.ncbi.nlm.nih.gov/27270453/ | https://doi.org/10.1016/j.cbi.2016.06.005 | Access: Indexed primary abstract/metadata only; unextracted doses, figures and methods remain unknown.
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.